Put Options on BABY on 2/11/2019

Natus Medical Incorporated (BABY) provides newborn care, neurology, and hearing and balance assessment healthcare products and services worldwide.

It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.

The company provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. It offers diagnostic electroencephalography (EEG), ambulatory EEG, and long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, intra-operative monitoring, and diagnostic and monitoring transcranial doppler ultrasound technology systems.

The company also provides hearing screening products to screen the hearing; diagnostic hearing assessment products to screen for or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers.

Shares have formed a bearish "flag" following the company's latest quarterly report. Lower share prices are expected for this stock.

Last Trade: $30.05

Trading Range: $27.69 - $37.95

Trade Buy 1 March $30.00 Put at $1.50 For a net debit of $1.50 Profit/Loss Analysis Breakeven at $28.50 Maximum profit is unbounded Maximum loss is ($150.00) at strike of $30.00 Closing Summary Sold 1 March $30.00 Put at $2.50

Position closed on 3/15/2019 at price of $2.50 with a 66.67% gain in 32 days.

Updates

3/15/2019 1:19:48 PM

BABY $30 Put option sold for $2.50

Back to Portfolio